- Report
- September 2025
- 83 Pages
Global
From €3500EUR$4,157USD£3,106GBP
- Report
- September 2025
- 72 Pages
Global
From €3500EUR$4,157USD£3,106GBP
- Report
- July 2025
- 112 Pages
Global
From €3500EUR$4,157USD£3,106GBP
- Report
- July 2025
- 85 Pages
Global
From €3500EUR$4,157USD£3,106GBP
- Report
- May 2025
- 99 Pages
Global
From €3500EUR$4,157USD£3,106GBP
- Report
- February 2024
- 202 Pages
Global
From €4510EUR$5,000USD£3,867GBP
- Report
- October 2025
- 80 Pages
Kuwait
From €4059EUR$4,500USD£3,480GBP
- Report
- September 2025
- 96 Pages
Germany
From €4059EUR$4,500USD£3,480GBP
- Report
- July 2025
- 150 Pages
Global
From €4374EUR$4,850USD£3,751GBP
- Report
- July 2025
- 140 Pages
Global
From €4374EUR$4,850USD£3,751GBP
- Report
- June 2025
- 90 Pages
United States
From €4059EUR$4,500USD£3,480GBP
- Report
- June 2025
- 138 Pages
Global
From €4374EUR$4,850USD£3,751GBP
- Report
- June 2025
- 90 Pages
Global
From €4374EUR$4,850USD£3,751GBP
- Report
- January 2025
- 230 Pages
United States
From €3157EUR$3,500USD£2,707GBP
- Report
- July 2024
- 90 Pages
China
From €1623EUR$1,800USD£1,392GBP
- Report
- July 2024
- 326 Pages
China
From €3608EUR$4,000USD£3,093GBP
- Report
- July 2024
- 187 Pages
China
From €1623EUR$1,800USD£1,392GBP
- Report
- January 2024
- 213 Pages
Global
From €4194EUR$4,650USD£3,596GBP
- Report
- September 2023
- 114 Pages
Global
From €2661EUR$2,950USD£2,281GBP
- Report
- September 2023
- 87 Pages
Middle East, Africa
From €2661EUR$2,950USD£2,281GBP

The Vaccine Development market is a subset of the Vaccines industry, which focuses on the research, development, and production of vaccines. Vaccines are biological preparations that provide active acquired immunity to a particular disease. Vaccine development involves the identification of antigens, the development of a vaccine formulation, and the production of the vaccine. Vaccine development is a complex process that requires significant resources and expertise.
The Vaccine Development market is highly competitive, with many companies competing to develop and produce vaccines. Companies in the market include Merck & Co., GlaxoSmithKline, Sanofi, Pfizer, Johnson & Johnson, and Novavax. Show Less Read more